Please use this identifier to cite or link to this item:
Title: Evaluation of progression free survival as surrogate endpoint for overall survival for prostate cancer treatment
Authors: Bigirumurame, Theophile
Advisors: SHKEDY, Ziv
Issue Date: 2012
Publisher: tUL Diepenbeek
Abstract: In some clinical research, the endpoint of greatest relevance to inferences concerning therapeutic efficacy is frequently not practical or even feasible to measure. Sometimes the determination of the true endpoint is difficult, requiring an expensive, invasive or uncomfortable procedure. In some trials, however, the main endpoint of interest, for example death, is rare and/or takes a long period of time to reach. In such trials, there would be benefit in finding a more proximate endpoint to determine more quickly the effect of an intervention. In this report, a meta-analytic approach was used to validate progression free survival as a surrogate for Overall Survival. Firstly the logarithm of both endpoints were assumed to be normally distributed and fixed effects models were applied to them. Secondly both endpoints were considered as failure time and appropriate methods were applied. In all cases, the individual and trial level surrogacy estimates were too low to be useful. It was
Notes: Master of Statistics-Biostatistics
Document URI:
Category: T2
Type: Theses and Dissertations
Appears in Collections:Master theses

Files in This Item:
File Description SizeFormat 
10299932011009.pdf1.82 MBAdobe PDFView/Open
Show full item record

Google ScholarTM


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.